Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.02 (-4.66%)
As of: Nov 16, 2026 · 3:48 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Gross Profit (2010 - 2011)

Updated

Protagenic Therapeutics, Inc.new's Gross Profit came in at $9.83 million for fiscal Q3 2013 (quarter ended Sep 30, 2011), up 257.3% from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Gross Profit (2010 - 2011) Analysis & Trends

Over the trailing twelve months to Sep 30, 2011, Protagenic Therapeutics, Inc.new reported Gross Profit of $21.07 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 9.83 Mn
Jun 30, 2011 2.75 Mn
Mar 31, 2011 3.58 Mn
Sep 30, 2010 4.92 Mn
Jun 30, 2010 5.82 Mn
Mar 31, 2010 6.22 Mn
API Access

Protagenic Therapeutics, Inc.new Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=PTIX&period=max&api_key=YOUR_API_KEY